Mechanisms of leucemogenesis;Mécanismes de la leucémogenèse

Bulletin du Cancer

Volumn 97, Issue 11, 2010, Pages 1381-1388

  Bernard, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chromosomal translocations; Leukaemias; Mutations; Oncogenesis; Transcriptome

Indexed keywords

CANCER GENETICS; DNA MICROARRAY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; ONCOGENE; REVIEW; STRUCTURAL CHROMOSOME ABERRATION; CHROMOSOME 11; CHROMOSOME ABERRATION; GENE FUSION; GENETICS; TWINS;

AML1 ETO FUSION PROTEIN, HUMAN; AML1-ETO FUSION PROTEIN, HUMAN; CBFBETA MYH11 FUSION PROTEIN; CBFBETA-MYH11 FUSION PROTEIN; CORE BINDING FACTOR BETA; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEOPHOSMIN; ONCOPROTEIN; RUNX1 PROTEIN, HUMAN; TEL RUNX1 FUSION PROTEIN, HUMAN; TEL-RUNX1 FUSION PROTEIN, HUMAN; TRANSCRIPTION FACTOR RUNX1;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; DISEASES IN TWINS; GENE FUSION; HUMANS; LEUKEMIA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION;

EID: 78650164974     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1210     Document Type: Review

References (23)

1. Passegue E, Jamieson CH, Ailles LE, Weissman IL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 2003 ; 100 (Suppl 1) : 11842-9.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976 ; 33 : 451-8.
3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009 ; 114 : 937-51.
4. Kelly LM, Gilliland DG. Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet 2002 ; 3 : 179-98.
5. Dick JE. Stem cell concepts renew cancer research. Blood 2008 ; 112 : 4793-807.
6. Frohling S, Dohner H. Chromosomal abnormalities in cancer. N Engl J Med 2008 ; 359 : 722-34.
7. Goldman JM. Initial treatment for patients with CML. Treatment strategies for CML. Hematology Am Soc Hematol Educ Program 2009 ; 22 : 453-60.
8. Druker BJ. Translation of the Philadelphia chromosome into therapy for CML Blood. 2008 ; 112 : 4808-17.
9. Downing JR. Cancer genomes: continuing progress. N Engl J Med 2009 ; 361 : 1111-2.
10. Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009 ; 23 : 1209-18.
11. Slany RK. The molecular biology of mixed lineage leukemia. Haematologica 2009 ; 94 : 984-93.
12. Harper DP, Aplan PD. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res 2008 ; 68 : 10024-7.
13. Link KA, Chou FS, Mulloy JC. Core binding factor at the crossroads: determining the fate of the HSC. J Cell Physiol 2010 ; 222 : 50-6.
14. Schindler JW, Van Buren D, Foudi A, Krejci O, Qin J, Orkin SH, et al. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 2009 ; 5 : 43-53.
15. Castilla LH, Garrett L, Adya N, Orlic D, Dutra A, Anderson S, et al. The fusion gene CBFB-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet 1999 ; 23 : 144-6. (Pubitemid 29455384)
16. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 2002 ; 1 : 63-74. (Pubitemid 41039177)
17. Greaves M. Darwin and evolutionary tales in leukemia. Hematology Am Soc Hematol Educ Program 2009 : 3-12.
18. Ferrando AA. The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program 2009 : 353-61.
19. Dohner H. Implication of the molecular characterization of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2007 : 412-9.
20. Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, Fenaux P, et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 2008 ; 22 : 915-31. (Pubitemid 351709343)
21. Nasr R, Lallemand-Breitenbach V, Zhu J, Guillemin MC, de The H. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Clin Cancer Res 2009 ; 15 : 6321-6.
22. Scaglioni PP, Pandolfi PP. The theory of APL revisited. Curr Top Microbiol Immunol 2007 ; 313 : 85-100.
23. Falini B, Sportoletti P, Martelli MP. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. Curr Opin Oncol 2009 ; 21 : 573-81.